BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
87 hedge funds and large institutions have $567M invested in Blueprint Medicines in 2016 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
54% less call options, than puts
Call options by funds: $425K | Put options by funds: $921K
Holders
87
Holding in Top 10
4
Calls
$425K
Puts
$921K
Top Buyers
| 1 | +$24.2M | |
| 2 | +$15.9M | |
| 3 | +$9.09M | |
| 4 |
DM
Deerfield Management
New York
|
+$6.4M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.87M |
Top Sellers
| 1 | -$32.5M | |
| 2 | -$11.6M | |
| 3 | -$7.18M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$5.18M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.64M |